Prospective study on prevalence of dermatological changes in patients under hemodialysis in hemodialysis units in Tanta University hospitals, Egypt

Mourad, Basma; Hegab, Doaa Salah; Okasha, Kamal; Rizk, Sarah

doi:10.2147/ccid.s70842

Cited by 12 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…12 The estimated pooled prevalence in this review was 52.3%. The [27,28,29,30,31] Included studies n= 04 being the most common ones), medication use, advanced age, restrictions in fluid intake, fibrosis and atrophy of minor salivary glands parenchyma and increased uraemia levels. 1,8,10,[13][14][15] Meta-analysis of the studies displayed high heterogeneity.…”

Section: Discussionmentioning

confidence: 99%

Prevalence of xerostomia in patients on haemodialysis: A systematic review and meta‐analysis

et al. 2021

View full text Add to dashboard Cite

End-Stage Renal Disease (ESRD) is a clinical state or condition which is a result of irreversible loss of kidney function. This causes the ESRD patients to permanently depend on dialysis or undergo kidney transplantation. The various causes of ESRD include diabetic nephropathy, congenital diseases, chronic glomerulonephritis and hypertension. 1 Of these, diabetes and hypertension are considered the most frequent causes of ESRD. 1,2 The severities of symptoms are usually intense and can be relieved to some degree by dialysis therapy. Haemodialysis is the ideal treatment modality which reduces the mortality of patients with

show abstract

Section: Discussionmentioning

confidence: 99%

Prevalence of xerostomia in patients on haemodialysis: A systematic review and meta‐analysis

et al. 2021

View full text Add to dashboard Cite

show abstract

“…In the second-half of the 20 th century discovery of renal replacement therapy has improved life expectancy of many individuals. Newer mucocutaneous changes have been documented since the discovery of hemodialysis, which extends life, and thus giving time to manifest these changes 2 .…”

Section: Introductionmentioning

confidence: 99%

An Observational Study of Dermatological Manifestations in Patients of Chronic Renal Failure Undergoing Hemodialysis

Kelkar

Kote

Gugle

et al. 2020

mvpjms

View full text Add to dashboard Cite

Background: Chronic Renal Failure (CRF) patients develop myriad of cutaneous findings. Novel cutaneous changes are being described since the introduction of hemodialysis, which prolongs the life expectancy, and thus more time for the skin changes to develop. Aims & Objectives: We aimed to evaluate the prevalence of dermatologic manifestations among the patients suffering from Chronic Renal Failure (CRF) who are on hemodialysis. Methods: 93 patients with CRF receiving hemodialysis were evaluated for skin, hair and nail changes. Results: All the enrolled patients experienced some skin problem. The most prevalent cutaneous manifestation was xerosis (54.8%), followed by pallor (21.5%), pruritus (19.35%) and dyspigmentation (18.3%). Other dermatologic manifestations included Kyrle's disease (5.4%); fungal (5.4%), bacterial (6.5%) and viral (3.2%) infections and purpura (9.7%). Recorded nail changes were half and half nail (21%), koilonychia (39.78%), onychomycosis (1.08%), onychorrhexis (6.45%), splinter hemorrhages (1.08%), and Beau's lines (2%). Hair changes included sparse hair (18.28%), and brittle and lustreless hair (11.83%). Oral cavity manifestations were enlarged tongue with teeth indentations (23.65%). Conclusions: CRF is associated with multiple skin, hair and nail manifestations caused either by the CRF or by its therapy. The commonest cutaneous changes were xerosis and pruritus.

show abstract

Les manifestations cutanées chez les patients hémodialysés chroniques dans un pays en voie de développement

Coulibaly¹,

Korsaga-Somé²,

Fomena³

et al. 2016

Pan Afr Med J

View full text Add to dashboard Cite

Le but de cette étude était deconnaître les affections cutanées les plus fréquentes chez les patients hémodialysés chroniques du Centre Hospitalier Universitaire Yalgado Ouédraogo (CHU-YO) de Ouagadougou. L’étude, de type transversal descriptif, menée du 15 Septembre au 31 Décembre 2014, s'estdéroulée au CHU-YO. Elle concernait les patients qui avaient au moins trois mois d'ancienneté en hémodialyse chronique. La fréquence des séances d'hémodialyse était d'une tous les cinq jours. Le seuil de signification des tests statistiques était défini pour une probabilité p ≤ 0,05. Quatre-vingt-quinze patients (61,1% d'hommes et 38,9% de femmes), de moyenne d’âge 42,1 ans participaient à l’étude. La durée moyenne en hémodialyse était de 31,9 mois. Le taux de réalisation des analyses biologiques variait de 7,4 à 85,3%. Quatre-vingt patients (85,3%) avaient au moins une manifestation cutanée. La xérose cutanée (67,4%), le prurit (45,3%), et l'hyperpigmentation (23,2%) étaient les plus fréquentes des manifestations cutanées pouvant être spécifiques de l'hémodialyse. L'hypomélanose en gouttes (11,6%), le prurigo (11,6%) et la folliculite (8,4%) étaient les principales manifestations cutanées non spécifiques. L'atteinte cutanée était fréquente mais ne semblait pas liée à l'ancienneté en hémodialyse. Les mauvaises conditions d'hémodialyse et l'environnement sec et chaud à Ouagadougou, ont pu favoriser ces atteintes, en particulier la xérose et le prurit. Une meilleure subvention des soins de santé contribuerait à réduire la prévalence des maladies cutanées et à améliorer la qualité de vie de nos patients hémodialysés chroniques.

show abstract

Prospective study on prevalence of dermatological changes in patients under hemodialysis in hemodialysis units in Tanta University hospitals, Egypt

Cited by 12 publications

References 21 publications

Prevalence of xerostomia in patients on haemodialysis: A systematic review and meta‐analysis

Prevalence of xerostomia in patients on haemodialysis: A systematic review and meta‐analysis

An Observational Study of Dermatological Manifestations in Patients of Chronic Renal Failure Undergoing Hemodialysis

Les manifestations cutanées chez les patients hémodialysés chroniques dans un pays en voie de développement

Contact Info

Product

Resources

About